Table 5.

The multivariate logistic regression analysis about each variable associated with achieving EASI 90 – female, TEC > 500 at 32 and 52 weeks, and LDH ≥ 250 at all time points showed significant difference, respectively.

Variables	OR	95% CI	P value	Variables	OR	95% CI	P value
Age over 30	0.627	0.275–1.405	0.259	TEC > 500 at baseline	0.621	0.234––1.606	0.330
Sex (female)	2.509	1.077–6.089	0.036	TEC > 500 at 16 weeks	0.477	0.197–1.115	0.093
Onset (adult)	1.004	0.174–5.801	0.996	TEC > 500 at 32 weeks	0.250	0.090–0.641	0.005
Concomitant treatment	0.384	0.114–1.158	0.100	TEC > 500 at 52 weeks	0.218	0.071–0.605	0.005
Concomitant treatment with cyclosporine	0.852	0.378–1.907	0.697	LDH > 250 at baseline	0.259	0.085–0.719	0.012
IgE > 100 at baseline	5.188	0.733–104.917	0.151	LDH > 250 at 16 weeks	0.264	0.079–0.788	0.022
IgE > 100 at 16 weeks	1.186	0.304–4.748	0.804	LDH > 250 at 32 weeks	0.136	0.033–0.446	0.002
IgE > 100 at 32 weeks	0.610	0.175–1.991	0.420	LDH > 250 at 52 weeks	0.068	0.003–0.600	0.037
IgE > 100 at 52 weeks	0.311	0.087–1.023	0.062

Each analysis was performed about the effect of each variable under adjustment to the baseline EASI, respectively.